@article{Naidoo_R-2024_200431,
title = {An evaluation of the national testing response during the COVID-19 pandemic in England: a multistage mixed-methods study protocol},
author = {Naidoo, R. and Lambert, B. and Voysey, M. and Shretta, R. and Keene, C. and Wanat, M. and Andersen-Waine, B. and Dahal, P. and Stepniewska, K. and Hounsell, R. and Molyneux, S. and Pinto-Duschinsky, S. and Rowe, E. and Yenidogan, G. and Fowler, T. and White, L. and Consortium, E.},
month = {jun},
year = {2024},
abstract = {IntroductionIn 2020, the UK government established a large-scale testing programme to rapidly identify individuals in England who were infected with SARS-CoV-2 and had COVID-19. This comprised part of the UK government’s COVID-19 response strategy, to protect those at risk of severe COVID-19 disease and death and to reduce the burden on the health system. To assess the success of this approach, the UK Health Security Agency (UKHSA) commissioned an independent evaluation of the activities delivered by the National Health System testing programme in England. The primary purpose of this evaluation will be to capture key learnings from the roll-out of testing to different target populations via various testing services between October 2020 and March 2022 and to use these insights to formulate recommendations for future pandemic preparedness strategy. In this protocol, we detail the rationale, approach and study design.},
volume = {14},
issue = {6},
journal = {BMJ Open},
publisher = {BMJ Publishing Group},
url = {https://doi.org/10.1136/bmjopen-2023-077271},
}
